Back
Alnylam Pharmaceuticals Vs. Strategy Industry Stock Comparison
Sell
33
ALNY
Alnylam Pharmaceuticals
Last Price:
$255.85
Seasonality Move:
7.6%
Sell
48
MSTR
Strategy
Last Price:
$306.07
Seasonality Move:
-5.9%
Sell
33
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $255.76. The Score for ALNY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Strategy (MSTR)
is a Sell
Is Strategy a Buy, Sell or Hold?
-
MSTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $255.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
MSTR Stock Price Chart
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.17 | Buy |
| Relative Strength Index (14 RSI): | 47.81 | Sell |
| Chaikin Money Flow: | -809168 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (239.46 - 269.34) | Buy |
| Bollinger Bands (100): | (240.63 - 269.83) | Buy |
MSTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.13 | Buy |
| Relative Strength Index (14 RSI): | 51.07 | Buy |
| Chaikin Money Flow: | 14812509 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (261.31 - 316.45) | Buy |
| Bollinger Bands (100): | (284.56 - 382.12) | Sell |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 273.68 | Sell |
| 20-day SMA: | 257.17 | Sell |
| 50-day SMA: | 260.57 | Sell |
| 200-day SMA: | 255.06 | Buy |
| 8-day EMA: | 266.02 | Sell |
| 20-day EMA: | 261.54 | Sell |
| 50-day EMA: | 258.26 | Sell |
| 200-day EMA: | 244.93 | Buy |
MSTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 314.89 | Sell |
| 20-day SMA: | 298.09 | Buy |
| 50-day SMA: | 315.67 | Sell |
| 200-day SMA: | 245.86 | Buy |
| 8-day EMA: | 306.14 | Sell |
| 20-day EMA: | 303.2 | Buy |
| 50-day EMA: | 308.97 | Sell |
| 200-day EMA: | 258.39 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.06 per share, an increase this year of $1.07 per share, and an increase next year of $2.78 per share.
Strategy Earnings Growth & MSTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $38.16 per share, an increase this year of $2.96 per share, and an increase next year of $0.01 per share.
Alnylam Pharmaceuticals Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Strategy Technical Analysis
| Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||